ExLibris header image
SFX Logo
Title: Flecainide enantiomers: Disposition in human subjects and electrophysiologic actions in vitro
Source:

Clinical Pharmacology & Therapeutics [0009-9236] Kroemer, Heyo yr:1989


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. McQuinn, Roy L. "Flecainide excretion in human breast milk." Clinical pharmacology and therapeutics 48.3 (1990): 262-267. Link to SFX for this item
2. Jaillon, M. "Variable disposition kinetics and electrocardiographic effects of flecainide during repeated dosing in humans: contribution of genetic factors, dose-dependent clearance, and interaction with amiodarone." Clinical pharmacology and therapeutics 55.3 (1994): 256-69. Link to SFX for this item
3. Wagner X, A. "Coadministration of flecainide acetate and sotalol during pregnancy: lack of teratogenic effects, passage across the placenta, and excretion in human breast milk." The American heart journal 119.3 (1990): 700-2. Link to Full Text for this item Link to SFX for this item
4. Munafo, A. "The effect of a low dose of quinidine on the disposition of flecainide in healthy volunteers." European journal of clinical pharmacology (1992): 441-443. Link to Full Text for this item Link to SFX for this item
5. Conard, G J. "The pharmacodynamic and pharmacokinetic interaction of flecainide acetate with propranolol: effects on cardiac function and drug clearance." European journal of clinical pharmacology 33.1 (1987): 97-99. Link to Full Text for this item Link to SFX for this item
6. Doki, K. "CYP2D6 genotype affects age-related decline in flecainide clearance." Pharmacogenetics and genomics 22.11 (2012): 777-783. Link to SFX for this item
7. Mitchell, L B. "Electropharmacology of amiodarone therapy initiation. Time courses of onset of electrophysiologic and antiarrhythmic effects." Circulation 80.1 (1989): 34-42. Link to SFX for this item
8. MIKUS, G. "THE INFLUENCE OF THE SPARTEINE DEBRISOQUIN PHENOTYPE ON THE DISPOSITION OF FLECAINIDE." Clinical pharmacology and therapeutics 45.5 (1989): 562-567. Link to SFX for this item
9. Hackett, L P. "Excretion of Sotalol in Breast Milk." British journal of clinical pharmacology 29.2 (1990): 277-278. Link to Full Text for this item Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.